Takeda Pharmaceutical Co Ltd
TAK- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001395064
In the last 90 days, Takeda Pharmaceutical Co Ltd insiders filed 0 open-market purchases and 19 sales; 379 institutions reported holding it in 13F filings for Q2 2026, worth $1.67B in total; no superinvestor holds it.
Other share classesTKPHF
Superinvestors holding TAK, Q2 2026
No superinvestor reported holding TAK in Q2 2026.
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of TAK each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q1 2022
0 superinvestors holding at quarter end
- Sold out
- ARK Invest
Q4 2021
1 superinvestor holding at quarter end
- Reduced
- ARK Invest (−41.8%)
Q3 2021
1 superinvestor holding at quarter end
- Reduced
- ARK Invest (−12.9%)
Q2 2021
1 superinvestor holding at quarter end
- Reduced
- ARK Invest (−17.2%)